dallas semaglutide intestinal paralysis lawsuit Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects dallas semaglutide gastric intestinal obstruction

From dosage management to lifestyle coaching, we're committed to your success every step of the way

If you experience persistent hiccups during GLP-1 therapy, understanding the mechanism can help guide a productive conversation with your provider

they prompt the body to release its own

days 1 to 30): 3 mg orally once a day Dose escalation (days 31 to 60): 7 mg orally once a day Maintenance dose (day 61 and onward): If no additional glycemic control is needed: 7 mg orally once a day If additional glycemic control is needed: 14 mg orally once a day SUBCUTANEOUS: Ozempic Injection: Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week Maintenance dose: 0.5 to 2 mg subcutaneously once a week, based on glycemic control If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dose: Increase to 1 mg subcutaneously once a week